Cargando…

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most common cause of cancer-related mortality worldwide. Due to the poor prognosis and limited therapeutic options, there is great interest in further understanding better the molecular underpinnings and potential molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valero, Vicente, Pawlik, Timothy M, Anders, Robert A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918286/ https://www.ncbi.nlm.nih.gov/pubmed/27508196 http://dx.doi.org/10.2147/JHC.S48505

Ejemplares similares

Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K
por: Cho, Yong suk, et al.
Publicado: (2018)

Doc2Hpo: a web application for efficient and accurate HPO concept curation
por: Liu, Cong, et al.
Publicado: (2019)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

Copper(II) hydrogenphosphate, CuHPO(4)
por: Günther, Christiane, et al.
Publicado: (2009)

HPOAnnotator: improving large-scale prediction of HPO annotations by low-rank approximation with HPO semantic similarities and multiple PPI networks
por: Gao, Junning, et al.
Publicado: (2019)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma
por: Zhao, Xiaofang, et al.
Publicado: (2020)

YAP and endothelin-1 signaling: an emerging alliance in cancer
por: Tocci, Piera, et al.
Publicado: (2021)

Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
por: Köhler, Sebastian, et al.
Publicado: (2019)

Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma
por: Gorji, Leva, et al.
Publicado: (2023)

Investigations on factors influencing HPO-based semantic similarity calculation
por: Peng, Jiajie, et al.
Publicado: (2017)

An online tool for measuring and visualizing phenotype similarities using HPO
por: Peng, Jiajie, et al.
Publicado: (2018)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

The Immunology of Hepatocellular Carcinoma
por: Lawal, Gbemisola, et al.
Publicado: (2021)

Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2022)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Synthesis and crystal structure of calcium hydrogen phosphite, CaHPO(3)
por: Phillips, Mark L. F., et al.
Publicado: (2019)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022)

hpO: Berufsvereinigung für heilkundlich praktizierte Osteopathie e.V.
Publicado: (2020)

hpO: Berufsvereinigung für heilkundlich praktizierte Osteopathie e. V.
Publicado: (2021)

hpO: Berufsvereinigung für heilkundlich praktizierte Osteopathie e. V.
Publicado: (2021)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019)

Neutral competition of stem cells is skewed by proliferative changes downstream of Hh and Hpo
por: Amoyel, Marc, et al.
Publicado: (2014)

The Emerging Role of Circular RNAs in Hepatocellular Carcinoma
por: Qiu, Li-Peng, et al.
Publicado: (2018)

The Emerging Role of Stress Granules in Hepatocellular Carcinoma
por: Dolicka, Dobrochna, et al.
Publicado: (2021)

Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
por: Abaza, Tasneem, et al.
Publicado: (2023)

Automatically transforming pre- to post-composed phenotypes: EQ-lising HPO and MP
por: Oellrich, Anika, et al.
Publicado: (2013)

Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis
por: Li, Shuang, et al.
Publicado: (2021)

Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress
por: Shannon, Alexander H, et al.
Publicado: (2022)

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017)

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
por: Chen, Zibo, et al.
Publicado: (2022)

NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling
por: Shin, Yuna, et al.
Publicado: (2022)

Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

The Emerging Role of MicroRNAs in Hepatocellular Carcinoma
por: Akkiz, Hikmet
Publicado: (2014)

Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2020)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g8q74giletv5o9bo6logpv4q76